Trump Signs Executive Orders On Drug Pricing, Resurrect Rules On Rebates, Importation
President Trump is expected to sign four sweeping executive orders intended to lower drug prices and resurrect measures to constrict Medicare rebates, tie prices for certain Medicare drugs to overseas prices, lower insulin prices and allow the importation of drugs from Canada, according to a FierceHealthcare report.
Trump touted the executive orders during an event on Friday, highlighting measures such as the drug rebate rule that his own administration previously scuttled.
